IDH1 and central nervous system cancer: Diffuse gliomas with IDH mutations and 1p/19q co-deletion correspond to oligodendrogliomas, while IDH mutant tumors lacking the co-deletion typically have TP53 mutations, ATRX alterations and are considered astrocytic in differentiation [11, 34, 41].